FIECON is the Health Economics & Outcomes Research (HEOR) practice of Acumetis, partnering with life sciences organizations to unlock the full value of their innovations and accelerate patient access worldwide. To reframe what’s possible, evidence must do more than satisfy requirements it must inform better decisions, resonate with real world stakeholders, and stand up to scrutiny across markets. FIECON supports teams from early development through launch and in line optimization, helping them navigate complexity with confidence and clarity. Our work brings together deep technical expertise in HEOR with strategic insight, ensuring that evidence generation, value demonstration, and access strategies are robust, relevant, and decision ready. We are known for challenging convention, applying innovative thinking, and translating complex economic and outcomes data into meaningful narratives that support access, reimbursement, and long term commercial success. Innovation is central to how we work. Our proprietary platforms and modelling capabilities are designed to improve efficiency, accuracy, and scalability enabling teams to move faster without compromising scientific rigor. Founded on a mission to use economics for the good of humanity, FIECON combines purpose driven values with scientific excellence. Through sustained charitable giving and a commitment to responsible business practices, we strive to create impact beyond individual engagements and contribute to better outcomes for patients and society. As part of Acumetis, FIECON plays a vital role in delivering a seamless continuum of integrated commercial support across the asset lifecycle, helping clients de risk critical decisions and ensure their innovations reach the patients who need them most.
| Website | https://acumetisglobal.com/ |
| Revenue | $16.5 million |
| Employees | 66 (66 on RocketReach) |
| Founded | 2015 |
| Phone | +44 1727 225601 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+18 more
(view full list)
|
| Industry | Business Consulting and Services, Advertising & Marketing, Business Services |
| Keywords | Health Economics, Health Consulting, Economic Modeling, Healthcare Consulting, Cost Effectiveness Analysis, Health Policy Analysis, Value Assessment, Pharmacoeconomics, Health Outcomes Research, Medical Technology Assessment, Market Access, Public Health, Health Equity, Global Health, Data Analysis, Policy Analysis, Research, Consulting Services, Nonprofit, Philanthropy |
| Competitors | HEOR, Valid Insight (part of the Bioscript Group), Mtech Access, BresMed, Putnam PHMR, PRIORITIS, an IQVIA business (view competitors) |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 541 Companies, NAICS Code 54191 Companies, NAICS Code 54 Companies, NAICS Code 5419 Companies, NAICS Code 541910 Companies |
Looking for a particular FIECON employee's phone or email?
The FIECON annual revenue was $16.5 million in 2026.
David Bryan is the CFO of FIECON.
66 people are employed at FIECON.
The NAICS codes for FIECON are [541, 54191, 54, 5419, 541910].
The SIC codes for FIECON are [873, 87].